Un equipo liderado por Núria Malats, del Centro Nacional de Investigaciones Oncológicas (CNIO), ha desarrollado un algoritmo que predice con precisión la existencia de metástasis a partir de imág...
Read moreIt has been analyzed recent advances in the diagnosis and treatment of primary autoimmune neuropathies—a group of rare and debilitating disorders of the peripheral nervous system that includes Guill...
Read moreThe findings suggest that inhibiting CNNM4, combined with GalNAc siRNA technology, could offer a targeted, safe, and effective treatment, opening new avenues for personalized therapies against this ag...
Read moreMuestran que esta flexibilidad depende del equilibrio entre dos tipos de mecanismos inhibitorios, que regulan cómo interactúan los ritmos lentos (theta) y rápidos (gamma). Gracias a este mecanismo,...
Read moreThe results obtained support the thesis that lactoferrin protects against intestinal inflammation by modulating serotonin.
Read moreA team from UPV and UV has developed a biosensor that detects airborne viruses in real time, quickly, easily and economically.
Read moreA systematic review published in eClinicalMedicine concludes that most antidepressants, when used appropriately, do not significantly increase the risk of a depressive episode turning into a manic epi...
Read moreAn international team led by the CBM in collaboration with CBGP has discovered that plant roots have an "internal clock" that governs when and how cells divide. This discovery explains how plants coor...
Read moreAn international group of experts has published in the journal Movement Disorders a scientific review that thoroughly analyzes the most widely used neuropsychological tools to assess attention, workin...
Read moreEl ácido alfa-lipoico (ALA) puede restaurar los niveles de frataxina y tener un impacto beneficioso en la función mitocondrial en modelos celulares derivados de pacientes con ataxia de Friedreich (F...
Read moreEl estudio sugiere actuar sobre el entorno del tumor, como alternativa a los tratamientos actuales que atacan directamente a las células tumorales
Read moreThe results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.
Read more